Key result
A 13-point checklist and framework is proposed to enhance outpatient guideline-directed management for the secondary prevention of atherosclerotic cardiovascular disease.
Why the study?
Current evidence indicates gaps in the management of patients with established ASCVD related to barriers to guideline implementation, creating a need for strategies to overcome these barriers.
A proposed 13-point checklist aims to overcome barriers to guideline implementation and improve evidence-based pharmacological and nonpharmacological care for patients with established ASCVD.
Answers are grounded in this paper and cite their sources.
Should not yet change ASCVD outpatient practice; leaves open whether the checklist improves adherence or outcomes.
Compelling results from clinical trials supporting intensive risk-reduction therapies to reduce associated morbidity and mortality in patients with established atherosclerotic cardiovascular disease (ASCVD) provided the impetus for medical societies to integrate these evidence-based results into clinical practice guidelines. Current evidence, however, points toward gaps in the management of patients with established ASCVD. Some of these gaps are related to barriers to guideline implementation, and strategies are needed to overcome these barriers. In this review, we propose a framework incorporating comprehensive tools for enhanced guideline-directed management in secondary prevention of ASCVD. This aid includes a 13-point checklist with supporting educational and system-based tools for effective evidence-based pharmacological and nonpharmacological care. This proposed tool targets primary care providers and cardiologists in the outpatient setting who provide direct medical care for patients with established ASCVD.
No takes yet. Share an insight, caveat, or question.
Taha et al. (2021) conducted a review in Atherosclerotic cardiovascular disease (ASCVD). 13-point checklist and framework was evaluated. A 13-point checklist and framework is proposed to enhance outpatient guideline-directed management for the secondary prevention of atherosclerotic cardiovascular disease.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: